Celina Dubin recently graduated from medical school with a distinction in research in May 2022. She is currently a resident physician in New York City, where she is training to become a dermatologist.
Celina Dubin
Claim This Podcastby Celina Dubin MD
29 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
Celina Dubin recently graduated from medical school with a distinction in research in May 2022. She is currently a resident physician in New York City, where she is training to become a dermatologist.
Language
🇺🇲
Publishing Since
10/26/2021
1 verified contact email on file for Celina Dubin
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 16, 2026
Celina Dubin, MD, attended Robin Hood’s annual gala on May 3, 2026, along with her parents, Glenn Dubin and Eva Andersson-Dubin, MD
Celina Dubin, MD, attended Robin Hood’s annual gala on May 3, 2026, along with her parents, Glenn Dubin and Eva Andersson-Dubin, MD. The event featured performances by P!nk, the Lumineers, and Pete Davidson and raised $73 million. READ MORE HERE: https://www.tradingview.com/news/gurufocus:d0e146f9b094b:0-robin-hood-reaches-70-of-1-billion-endowment-goal/ https://robinhood.org/news/robin-hood-endowment-launch-benefit-2026/
May 28, 2026
Celina Dubin MD-Using random forest models to predict drug reaction with eosinophilia and systemic symptoms development from CBC parameters
This article was co-authored by Celina Dubin, MD, a dermatology resident at the Icahn School of Medicine at Mount Sinai, and was published in the Journal of Investigative Dermatology. Read the original abstract here: https://www.jidonline.org/article/S0022-202X(25)00645-1/fulltext
May 18, 2026
Celina Dubin MD et al- The use of oral dutasteride, minoxidil, and finasteride for treating endocrine therapy-induced hair loss from breast cancer treatment. A case series study
Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this case series study, which was published in the Journal of the American Academy of Dermatology Case Reports. LEARN MORE IN THE FULL ARTICLE IN JAAD CASE REPORTS HERE: https://www.jaadcasereports.org/article/S2352-5126(25)00601-0/fulltext
29 total episodes available
Deep-dive analytics for Celina Dubin
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Celina Dubin?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.